| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James B. Breitmeyer | Chief Executive Officer, Director | $325,311 | 14 Feb 2024 | ||
| HALE DAVID F | Director | $282,989 | 20 Jun 2024 | ||
| Robert James Wills | Director | $89,613 | 20 Jun 2024 | ||
| Richard G. Vincent | Chief Financial Officer | $73,066 | 14 Feb 2024 | ||
| Salim Yazji | Chief Medical Officer | $63,816 | 14 Feb 2024 | ||
| Gunnar F. Kaufmann | Chief Scientific Officer | $46,994 | 12 Jun 2023 | ||
| Chase C. Leavitt | General Counsel/Secretary | $42,048 | 14 Feb 2024 | ||
| Rajesh Krishnan | Cto/Cso | $21,838 | 14 Feb 2024 | ||
| William R. Larue | Director | 20 Jun 2024 | |||
| Rosemary Mazanet | Director | 20 Jun 2024 | |||
| Daniel L. Kisner | Director | 20 Jun 2024 | |||
| Michael G. Carter | Director | 20 Jun 2024 | |||
| Jill DeSimone | Director | 20 Jun 2024 | |||
| Charles Theuer | Director | 20 Jun 2024 | |||
| Jinzhu Chen PhD | Director | 16 Jun 2022 | |||
| Xin Nakanishi | Director | 28 Jun 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||